2Schmidt IJ.A better model of a cuee pancreatitis for evaluating therapy.Am Surg,1992,215:44-49.
3Jin Z,Du Y,Li Z,et al.Endoscopic ultrasonography-guidod interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma:a prospective piostudy.Endoscopy,2008,40:314-320.
4Guo JH,Teng G J,Zhu GY,et al.Self-expandable esophageal stent loaded with ^125I seeds:initial experience in patients with advanced esophageal cancer.Radiology,2008,247:574-581.
7Taschereau R,Roy R,Pouliot J.Relative biological effectiveness enhancement of ^125I brachytherapy seed with characteristic x rays from its constitutive materials.Med Phys,2002,29:1397-1402.
6Chiu CJ,McArdle AH,Brown R,et al. Intestinal mucosal lesion in low-flow states. Ⅰ. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg, 1970, 101: 478-483.
7Nath R, Anderson LL, Luxton G, et al. Dosimetry of interstitial brachytherapy sources:recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicistsin Medicine. Med Phys, 1995,22:209-234.
8Wheeler JMD, Warren BF, Mortensen NJMcC, et al. Quantification of histologic regression of rectal cancer after irradiation a proposal for a modified staging system, Dis Colon Rectum, 2002,45 : 1051-1056.
9Cox JD, Stetz J, Pajak T F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC), Int J Radiat Oncol Biol Phys,1995,31 : 1341-1346.
10Monk BJ,Tewari KS,Puthawala AA,et al.Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation.Int J Radiat Oncol Biol Phys,2002,52:806-815.